APRE vs MSFT: Which Stock is Better?
Side-by-side comparison of Aprea Therapeutics Inc and Microsoft Corp in 2026
APRE
Aprea Therapeutics Inc
$0.88
MSFT
Microsoft Corp
$454.79
Key Metrics Comparison
| Metric | APRE | MSFT | Winner |
|---|---|---|---|
| Market Cap | $6.22M | $3.38T | MSFT |
| P/E Ratio | N/A | 36.30 | MSFT |
| EPS (TTM) | $N/A | $13.70 | MSFT |
| Revenue Growth | -1.0% | 14.9% | MSFT |
| Gross Margin | -1619.1% | 68.8% | MSFT |
Analyze APRE
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APRE or MSFT a better investment?
Comparing APRE and MSFT: Aprea Therapeutics Inc has a market cap of $6.22M while Microsoft Corp has $3.38T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APRE and MSFT?
APRE (Aprea Therapeutics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APRE or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: APRE or MSFT?
MSFT has higher revenue growth at 14.9% vs -1.0% for APRE.
Which company is more profitable: APRE or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to -1619.1% for APRE.
Which is the larger company: APRE or MSFT?
Microsoft Corp (MSFT) is larger with a market cap of $3.38T compared to $6.22M for APRE.
Should I buy APRE or MSFT in 2026?
Both APRE and MSFT have investment merit. APRE trades at $0.88 while MSFT trades at $454.79. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APRE and MSFT stock?
Key differences: Market Cap ($6.22M vs $3.38T), P/E Ratio (N/A vs 36.3x), Revenue Growth (-1.0% vs 14.9%), Gross Margin (-1619.1% vs 68.8%).